Philip Morris files Form 144 to sell 1,000 shares

Rhea-AI Filing Summary

Philip Morris International reported an intended sale of 1,000 shares of Common Stock under Form 144 through UBS Financial Services Inc. The filing lists two vested restricted awards—428 shares (02/16/2022) and 572 shares (02/15/2023)—and shows a planned sale date of 02/20/2026 by wire.

Insights

Corporate Governance Analyst

Routine insider resale of vested awards by an executive/entity.

The filing lists a resale of 1,000 shares of Common Stock via UBS Financial Services Inc. and identifies two vested restricted awards of 428 and 572 shares with grant dates 02/16/2022 and 02/15/2023

Timing is explicit with a sale method of wire and a planned sale date of 02/20/2026. Cash‑flow treatment and proceeds recipient follow standard resale mechanics; subsequent filings may report executed transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Philip Morris International's Form 144 report?

It reports an intended resale of 1,000 shares of Common Stock through UBS Financial Services Inc. The filing lists two vested restricted awards of 428 and 572 shares with a planned wire sale on 02/20/2026.

Who is the broker handling the sale in the PM Form 144?

The filing names UBS Financial Services Inc. at 1000 Harbor Blvd, Weehawken, NJ. That broker is listed as the intermediary for the 1,000-share resale scheduled for 02/20/2026 by wire.

Are the shares in the Form 144 newly issued or vested awards?

The shares are from vested restricted awards: one grant of 428 shares (granted 02/16/2022) and one of 572 shares (granted 02/15/2023), cited as the securities to be sold on 02/20/2026.

Does the Form 144 state how proceeds will be used by Philip Morris (PM)?

The filing lists a planned wire sale of 1,000 shares but does not state use of proceeds. The document identifies the securities and broker; it does not specify proceeds allocation or recipient details.

When is the planned sale date listed in the Form 144 for PM?

The Form 144 lists a planned sale date of 02/20/2026 with the sale method shown as a wire. Grant dates for the underlying vested awards are 02/16/2022 and 02/15/2023.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 02:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002013215
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Philip Morris Int
SEC File Number	001-33708
Address of Issuer	677 Washington Blvd Suite 1100 Stamford CONNECTICUT 06901
Phone	2039052410
Name of Person for Whose Account the Securities are To Be Sold	CRISTINA HARUMI OKA DOBROWOLSKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Member of immediate family of any of the foregoing

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1000	183580	1556679579	02/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/16/2022	Vested Restricted Award	Philip Morris Int			428	02/20/2026	Wire
Common Stock	02/15/2023	Vested Restricted Award	Philip Morris Int			572	02/20/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for CRISTINA HARUMI OKA DOBROWOLSKI
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)